John J. Toole, MD, PhD

Senior Vice President, Corporate Development

Dr. Toole was appointed to Senior Vice President, Corporate Development in March 2008. In this role, he is responsible for setting the strategy for and managing the company's business development and alliance management activities. Dr. Toole joined Gilead in April 1990 as Director of Molecular and Cellular Biology and was promoted to Vice President, Biology in May of 1996. In 1998 he transitioned to Vice President, Clinical Research and in August 2003 was promoted to Senior Vice President, Clinical Research. Prior to joining Gilead Dr. Toole was a recipient of an American Cancer Society Postdoctoral Fellowship, and performed his postdoctoral work in molecular biology at the Harvard Medical School and the Massachusetts Institute of Technology. Dr. Toole was one of the founding scientists of Genetics Institute, Inc., where he led the project team that first cloned the human coagulation factor VIII gene.

He received his PhD in Molecular Biology from the State University of New York at Buffalo, and his MD from the Stanford University School of Medicine.